Glycation is the process of bonding of a sugar molecule. For instance, glucose to a protein or a lipid molecule such as albumin. Glycated albumin is glucose bonded to an albumin molecule. Protein molecule i.e. albumin is present in blood, major body organs, and in body fluids. Function of albumin is to maintain shape of the cell, distribution of hormones, and nutrients. The amount of albumin decreases in the body when blood glucose levels are low and the amount of albumin increases in the body when blood glucose levels are high. Glycated albumin is measured during initiation of diabetes therapies to determine medication dose for treatment of diabetes.
According to a study conducted by American Association for Clinical Study, in 2011, glycated albumin have been described as novel biomarkers for the detection and management of diabetes. Treatment of diabetes require glycemic control. There are various measurements used to provide indicators, which includes glycated hemoglobin (HbA1c), 1,5-anhydroglucitol (1,5AG) and glycated albumin.
Glycated hemoglobin (HbA1c) indicates the glycemic level during the first three months of diabetes. This measurement is useful for the confirmation of short term therapeutic efficacy during initiation of the treatment for diabetes. Glycated albumin assay is more useful for pregnant women suffering from diabetes.
Glycated Albumin Assay Market Drivers:-
Approval of new products for detection of diabetes is expected to drive the global glycated albumin assay market growth. For instance, in 2011, Diazyme Laboratories, Enzymatic glycated serum protein (GSP, Glycated Albumin) Assay Kit was approved by the U.S. Food and Drug Administration (FDA). Enzymatic glycated serum protein (GSP, Glycated Albumin) Assay is two part liquid stable reagent, which can be used with various types of automated clinical chemistry analyzers. This product provides additional diagnostic values to clinical practices in diabetes management and screening. Thus, approval of products to manage diabetes in a rapid and accurate way is expected to drive glycated albumin assay market growth.
High prevalence of diabetes is expected to drive glycated albumin assay market growth. According to a survey conducted by National Institute of health (NIH), in 2016, more than 62 million people are diagnosed with diabetes in India.
Availability of alternative diabetes diagnosis method such as glucometer is expected to restrain the market growth. Furthermore, the vulnerability of variations offered by the test is also expected to decrease the adoption of glycated albumin assay, which in turn is restraining market growth
Glycated Albumin Assay Market Regional Analysis:-
North America is expected to dominate the global glycated albumin assay market due to high prevalence of diabetes. According to a survey conducted by Center for disease control and prevention (CDC), in 2016, more than 30.3 million people in the U.S. are diagnosed with diabetes that accounts for around 9% of the U.S. population. More than 84.1 million people in U.S. are diagnosed with prediabetes. Such high prevalence of diabetes in U.S. is expected to boost growth of global glycated albumin assay market.
Asia Pacific glycated albumin assay market is expected to witness significant growth due to FDA approvals of products launched by key players in this market. For instance, in 2017, Asahi Kasei Pharma Corporation, manufacturer of pharmaceuticals and pharmaceutical intermediates, received an approval for their new product, Lucica glycated albumin –L. It is an in vitro diagnostic assay kits. Asahi Kasei Pharma Corporation leveraged its own original enzymes to develop glycated albumin assay kits for use with biochemical auto analyzer. Approval of new product to manage diabetes is expected to drive glycated albumin assay market growth.
Glycated Albumin Assay Market Key Players:-
Key players operating in global glycated albumin assay market include Epinex Diagnostics Inc., Simes Sikma biotechnology Co. Ltd., Ningbo Purebio biotechnology Co. Ltd., Asahi Kasei Pharma Corpoation, Life Span Diabetes Clinic, Exocell Inc., Diazyme Laboratories, Maccura Biotechnology Co. Ltd., and Abnova Corporation. These companies sell variety of products for diabetes monitoring. For instance, Epinex Diagnostics Inc.’s product includes Epinex G1A test. Epinex G1A test is a rapid diabetes monitoring index test, it is a monthly test to control the glycation. It allows earlier therapeutic intervention and also stores patient test results.
Glycated Albumin Assay Market Taxonomy:-
By Product Type:-
By End Users:-
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.